Results 141 to 150 of about 63,667 (225)

Real-world pharmacovigilance of drug-induced osteoporosis: a focus on antiretroviral therapy and toxicological mechanisms in the elderly. [PDF]

Front Pharmacol
Liu X, Gong Y, Liu L, Wang X, Hu K, Song M, Song Y.   +6 more
europepmc   +1 more source

Use of dual ART in individuals with different HBV serological patterns. [PDF]

Curr Opin HIV AIDS
Swaine T, Bhagani S.
europepmc   +1 more source

Comparative Renal Safety of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A Korean Nationwide Study. [PDF]

J Korean Med Sci
Lim J, Yang J, Kim YJ, Kim HJ, Choi J.
europepmc   +1 more source

Pharmacological evaluation of an ex vivo cervicovaginal HIV prevention model. [PDF]

J Antimicrob Chemother
Collins LB, Le A, Nicol MR.
europepmc   +1 more source

Brief Report: Postpartum Maternal Monitoring for Renal Safety Related to Tenofovir Exposure During Breastfeeding in the PROMISE 1077BF Randomized Trial. [PDF]

J Acquir Immune Defic Syndr
Baltrusaitis K, Tierney C, Fowler MG, Owor M, Nematadzira TG, Nyakudya L, Cassim H, de Jager J, George K, Heckman B, Knowles K, Browning R, Siberry GK, Taha TE, Stranix-Chibanda L, PROMISE P1084s Study Team.   +15 more
europepmc   +1 more source

Tenofovir-induced Fanconi syndrome: a case report and literature review. [PDF]

Oxf Med Case Reports
Park J, Lee F, Yeam A, Hamiduzzaman A, Anavim A, Lau WL.   +5 more
europepmc   +1 more source

Comparable efficacy of bictegravir/emtricitabine/tenofovir alafenamide and doravirine/lamivudine/tenofovir disoproxil fumarate in therapy-naive Human Immunodeficiency Virus adults with very high baseline viraemia. [PDF]

J Med Microbiol
Calza L, Giglia M, Rigamonti C, Zuppiroli A, Marzolla D, Bon I, Viale P.   +6 more
europepmc   +1 more source

Cost and cost effectiveness of Herpes simplex virus-type 2 (hsv-2) suppressive therapy in HIV-1 and HSV-2 infected women in Johannesburg, South Africa [PDF]

, 2009
Bachmann, M, Delany-Moretlwe, S, Devine, A, Edwards, M, Foss, A, Mayaud, P, Meyer-Rath, G, Vickerman, P   +7 more
core  

R263K-associated dolutegravir resistance on tenofovir, lamivudine and dolutegravir: Implications for earlier genotyping and regimen optimisation. [PDF]

S Afr J Infect Dis
Naidoo S.
europepmc   +1 more source

In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort. [PDF]

Clin Infect Dis
Mann SC, Lykins D, Coyle RP, Witt MD, Kim EY, Macatangay B, Brown TT, Dionne JA, Alcaide M, Lahiri CD, Ramirez C, Dumond JB, D'Souza G, Cohen MH, Wilson TE, Kassaye S, Tien PC, Adedimeji AA, Ellison L, Brooks KM, Bushman LR, Anderson PL, MaWhinney S.   +22 more
europepmc   +1 more source